QED Bioscience is among the leading manufacturers of monoclonal and polyclonal antibodies. The company offers a comprehensive catalog of antibody products for many research areas, including cancer, neuroscience, apoptosis, infectious diseases, biowarfare agents, DNA, hormones and enzymes. Its capabilities include genetic immunization, hybridoma development, peptide antigen evaluation, antibody production and cell culture services. QED Bioscience develops products for a wide range of academic, biotechnology and pharmaceutical research clients. The company also features immunochemistry services, such as purification and conjugation. It maintains an international network of distributors. QED Bioscience has operated for more than 23 years and is headquartered in San Diego.